Brand Name news from FierceHealthcare
News
Express Scripts pays $9.5M settlement over drug switching
Pharmacy benefit manager Express Scripts has agreed to pay a total of $9.5 million to 28 states and the District of Columbia to settle allegations that it engaged in deceptive prescription-switching Read more...
FTC: Pharmas cut 14 deals to delay generic sales in '07
Makers of brand-name prescription drugs reached 14 agreements with makers of generic drugs to delay the generic drug makers entry into the market, according to a new report released by the Federal Read more...
SPOTLIGHT: Bill would allow FDA to improve generic biotech drugs
Two members of Congress have introduced a bill that would allow the FDA to approve generic versions of biotechnonology drugs, though it also would allow companies making brand-name biotech drugs to Read more...
SPOTLIGHT: Prescription drug sales slowing
It's hard to imagine, given the barrage of direct-to-consumer ads, armies of pharma reps replete with wining and dining privileges, prescription data-mining and the like, but the stats say drug Read more...
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies